Top Ancillary Cannabis Stocks for September 2023

Are These Ancillary Pot Stocks On Your Watchlist This Month?

The post Top Ancillary Cannabis Stocks for September 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
1606 Corp Engages AR XTLabs to Develop AI Chatbot For CBD Industry
Ryan Allway September 7th, 2023 News, Top News SEATTLE, Sept. 7, 2023 /PRNewswire/ — CBDW AI, a brand of 1606 Corp. (OTC: CBDW) and the new prominent provider of enterprise-level artificial intelligence (AI) solutions tailored for the CBD industry, is thrilled to reveal its strategic partnership with AR XTLabs, a leading... Read more
AbbVie (ABBV) to Present at the Morgan Stanley Healthcare Conference

AbbVie to Present at the Morgan Stanley Healthcare Conference AbbVie (NYSE: ABBV)…

The post AbbVie (ABBV) to Present at the Morgan Stanley Healthcare Conference appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
22nd Century Group, Inc. (XXII) Initiates Strategic Alternatives Process for Its Tobacco Assets
Green Thumb Industries Inc. (GTBIF) Announces Share Repurchase Program

Green Thumb Industries Announces Share Repurchase Program Green Thumb Industries Inc. (“Green…

The post Green Thumb Industries Inc. (GTBIF) Announces Share Repurchase Program appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
3 Marijuana Stocks To Buy This Upcoming Week
3 Marijuana Stocks For Better Trading In September
High Tide Announces At-The-Market Program of up to CAD$30,000,000 for Strategic Initiatives to Replace Previous At-The-Market Program
Ryan Allway September 1st, 2023 News, Top News CALGARY, AB, Sept. 1, 2023 /CNW/ – High Tide Inc. (“High Tide” or the “Company“) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to announce that in order to replace... Read more
September 2023’s Top Marijuana Penny Stocks to Watch
Number of Clinical Trials Using Cannabis-Based Medicines to Treat Symptoms From Conditions Like Cancer Increases by 650% Since 2010, Report Finds
Ryan Allway August 31st, 2023 News, Top News Key Findings: Pain, from various conditions, is by far the most prevalent symptom treated in clinical trials involving cannabinoids – with pain being the target condition in 46% of trials since 2010. The most commonly featured conditions in the patent landscape... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )